2022
DOI: 10.1038/s42003-022-03305-z
|View full text |Cite
|
Sign up to set email alerts
|

Targeting colonic macrophages improves glycemic control in high-fat diet-induced obesity

Abstract: The obesity epidemic continues to worsen worldwide. However, the mechanisms initiating glucose dysregulation in obesity remain poorly understood. We assessed the role that colonic macrophage subpopulations play in glucose homeostasis in mice fed a high-fat diet (HFD). Concurrent with glucose intolerance, pro-inflammatory/monocyte-derived colonic macrophages increased in mice fed a HFD. A link between macrophage numbers and glycemia was established by pharmacological dose-dependent ablation of macrophages. In p… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 67 publications
0
10
0
Order By: Relevance
“…The increased colon length in IMQ-pso mice confirmed the increased fermentative activity of the microbiota commonly associated with succinate production (Armstrong et al, 2021). Increased microbiota-derived succinate has been reported in other non-communicable diseases such as IBD and associated comorbidities, including arthritis and calcium oxalate kidney stones (Fremder et al, 2021), as well as in obesity, a condition in which increased numbers of pro-inflammatory intestinal macrophages were reported (Rohm et al, 2021(Rohm et al, , 2022. While succinate can be used as a source of nutrients for intestinal pathogen Article ll OPEN ACCESS colonization or proliferation (Fernandez-Veledo and Vendrell, 2019;Fremder et al, 2021), it may also contribute to the stable colonization by pathobionts, perpetuating dysbiosis in psoriasis.…”
Section: Discussionmentioning
confidence: 55%
“…The increased colon length in IMQ-pso mice confirmed the increased fermentative activity of the microbiota commonly associated with succinate production (Armstrong et al, 2021). Increased microbiota-derived succinate has been reported in other non-communicable diseases such as IBD and associated comorbidities, including arthritis and calcium oxalate kidney stones (Fremder et al, 2021), as well as in obesity, a condition in which increased numbers of pro-inflammatory intestinal macrophages were reported (Rohm et al, 2021(Rohm et al, , 2022. While succinate can be used as a source of nutrients for intestinal pathogen Article ll OPEN ACCESS colonization or proliferation (Fernandez-Veledo and Vendrell, 2019;Fremder et al, 2021), it may also contribute to the stable colonization by pathobionts, perpetuating dysbiosis in psoriasis.…”
Section: Discussionmentioning
confidence: 55%
“…These effects could in addition be further modified by biological sex, which influences both immunity and metabolism (Tramunt et al ., 2020; Breznik et al ., 2021b). It has been reported that TNF-producing monocyte-derived colon macrophages contribute to obesity-associated metabolic dysfunction in male mice (Kawano et al ., 2016; Rohm et al ., 2022). However, we have observed that while both obese male and female mice have an increase in circulating inflammatory TNF-producing Ly6C high monocytes and adipose tissue macrophage accumulation, in female mice the metabolic dysregulation is attenuated, and these changes are not dependent on TNF (Breznik et al ., 2018; Breznik et al ., 2021b).…”
Section: Discussionmentioning
confidence: 99%
“…Obesity increases circulating Ly6C high monocytes (Breznik et al ., 2018; Breznik et al ., 2021a), which differentiate into pro-inflammatory macrophages within metabolic tissues like adipose (Weisberg et al ., 2003; Kanda et al ., 2006). While it has been reported that there is an accumulation of pro-inflammatory macrophages within the colon in obesity (Kawano et al ., 2016), which could contribute to observations of obesity-associated increases in gut permeability (Cani et al ., 2007; Cani et al ., 2008; Johnson et al ., 2015; Kawano et al ., 2016), there is a lack of consensus across published research (Garidou et al ., 2015; Johnson et al ., 2015; Hong et al ., 2017; Luck et al ., 2019; Rohm et al ., 2022). This is likely due to differences in the methods and tissue regions of assessment, length of diet allocation, and selection of appropriate surface antigens to identify macrophages as well as to distinguish their monocyte-derived or tissue-resident characteristics.…”
Section: Introductionmentioning
confidence: 99%
“…The known effects of SCFAs in the intestine include enhancing the gut barrier function and exerting anti-inflammatory effects by acting on ileal epithelial cells, enteroendocrine cells and immune cells [11]. To evaluate the effects of voglibose on ileal function, the histological alteration of ileum tissue was evaluated using hematoxylin and eosin (H&E) staining.…”
Section: Voglibose Alleviates Ileal Inflammation and Maintains Intest...mentioning
confidence: 99%
“…In the healthy intestine, most macrophages maintain anti-inflammatory and resident subpopulations, whereas those with the pro-inflammatory phenotype have elevated expression of the nuclear factor kappa B (NF-κB) and tumor necrosis factor-alpha (TNF-α) when eating a high-fat diet (HFD) [9]. Colonic pro-inflammatory macrophages regulate glycemic control in mice fed an HFD as their numbers increase and alter glucose tolerance and peripheral insulin resistance [10,11]. Thus, the differentiation from pro-inflammatory macrophages toward anti-inflammatory subsets initiated by SCFAs could be a novel therapeutic method for T2DM.…”
Section: Introductionmentioning
confidence: 99%